Nav: Home

Cancer survivors: A growing population

June 02, 2016

ATLANTA - June 2, 2016 -There were more than 15.5 million Americans with a history of cancer as of January 1, 2016, a number that is projected to reach more than 20 million by 2026. That's according to Cancer Treatment and Survivorship Statistics, 2016, published in CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society, and its companion publication for consumers, Cancer Treatment & Survivorship Facts & Figures, 2016-2017. The report was released ahead of National Cancer Survivors Day, Sunday June 5, 2016.

Although overall cancer incidence rates are declining in men and stable in women, the number of cancer survivors continues to increase in the United States because of a growing and aging population, as well as increases in cancer survival because of advances in early detection and treatment.

The report is produced every two years in collaboration with the National Cancer Institute to estimate the numbers of current and future cancer survivors to help the public health community better serve this unique population, many of whom cope with long-term physical effects of treatment as well as psychological and socioeconomic sequelae.

The three most prevalent cancers in 2016 are prostate (3,306,760), colorectal (724,690), and melanoma (614,460) among men and breast (3,560,570), uterine corpus (757,190), and colorectal (727,350) among women. The distribution of prevalent cancers (the number of previously diagnosed cancers among people who are alive) differs from incident cancers (the number of newly diagnosed cancers). For example, lung cancer is the second most commonly diagnosed cancer in men, but ranks eighth in prevalence, largely because of poor survival.

One-third of survivors in the U.S. today were diagnosed less than five years ago and more than one-half (56%) were diagnosed within the past 10 years. Nearly half (47%) are age 70 years or older, although age distribution varies by cancer type. For example, the majority of prostate cancer survivors (64%) are age 70 years or older, compared to just one in three (37%) melanoma survivors. The report estimates that there are 65,190 cancer survivors aged 14 and under and 47,180 aged 15 to 19 years in the United States.

In the article, the term "cancer survivor" is used to describe a person who has a history of cancer, from the time of diagnosis through the remainder of his or her life. It includes patients currently undergoing treatment and those who may have become cancer-free. It is important to note that not all people with a history of cancer identify with the term "cancer survivor."

"People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers," write the authors. "Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care."

The report says identification of the best practices for delivering quality posttreatment cancer care is needed and points to ongoing efforts by the American College of Surgeons, the Alliance for Quality Psychosocial Cancer Care, and the American Cancer Society (ACS). The ACS has begun to produce guidelines to assist primary care and other clinicians in the provision of care for people with a history of cancer.

The American Cancer Society, the National Cancer Institute of the National Institutes of Health, the Centers for Disease Control and Prevention, and the LIVESTRONG Foundation will host the 8th Biennial Cancer Survivorship Research Conference, "Innovation in a Rapidly Changing Landscape," at the Omni Shoreham Hotel in Washington, D.C., June 16-18, 2016. The meeting will serve as a forum for researchers, clinicians, cancer survivors, advocates, program planners, policy-makers, and public health experts to learn about current and emerging cancer survivorship innovation in a rapidly changing landscape. For more information, visit: http://www.cancer.org/subsites/survivorship2016/
-end-
Article: Cancer Treatment and Survivorship Statistics, 2016, CA: Can J Clin doi: 10.3322/caac.21349.

American Cancer Society

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.